Occlutech PFO Occluder​
Designed for safety and excellence
procedural success rate
efficient closure rate after six months
force free angulation during release °
- The Occlutech PFO Occluder has conformable Nitinol braiding with a biocompatible titanium oxide surface
- Optimized braiding: no hub on the left atrial disc to facilitate endothelization
- Biocompatible Polyethylenterephthalat (PET) patch allows immediate verification of the occlusion effect by ultrasound and X-ray
- The ball connection allows up to a 50 degree angle which is intended to reduce tension on the septum, and allow septal alignment prior to release
- PFO closure using the Occlutech PFO Occluder reduces recurrent stroke ascribed to PFO. This reduction was proven successfully in retrospective and prospective clinical trials
- Mean procedure time: less than 30 minutes with reduced (P = 0.47) mean fluoroscopic time less than 4.4 mins
- The Occlutech PFO Occluder shows procedural success rate of 99% with efficient closure in 95.5% after six months
Material and design characteristics
Animation showing the mechanism of a PFO related cryptogenic stroke in a general way
Animation showing how an Occlutech PFO Occluder is implanted in a general way
TEE cross section of an optimally
implanted Occlutech PFO Occluder.
The hubless distal disc in 3-D TEE projection.
The Occlutech PFO Occluder in X-ray view.